Jan 06, 2020
New FDA-approved cystic fibrosis medicine, Trikafta®, among other specialty drugs available through AllianceRx Walgreens Prime
Nov 07, 2019
Proteostasis Therapeutics Reports Third Quarter 2019 Financial Results and Provides Corporate Update
Nov 06, 2019
AllianceRx Walgreens Prime study demonstrates favorable adherence, but high cost for cystic fibrosis patients prescribed modulator medications
Oct 24, 2019
Proteostasis Therapeutics Announces Presentations Highlighting its CFTR Modulators at the North American Cystic Fibrosis Conference
Oct 21, 2019
FDA approves new breakthrough therapy for cystic fibrosis
Jun 21, 2019
FDA expands approval of treatment for cystic fibrosis to include patients ages 6 and older
May 08, 2019
Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Dec 20, 2018
Proteostasis Therapeutics Provides Clinical Enrollment Update
Jun 26, 2018
Novel Drugs and Smart Devices for Respiratory Disorders, 2018 - 2030
Jun 25, 2018
Global Cystic Fibrosis Industry
Jun 25, 2018
BNBuilders Completes Construction on Vertex Pharmaceuticals Research Center in San Diego
Jun 06, 2018
Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy
Jun 01, 2018
Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference
May 08, 2018
Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis
Apr 17, 2018
Proteostasis Receives Endorsement from the Cystic Fibrosis Foundation's Therapeutic Development Network for the Study of the Company's Amplifier, PTI-428, in CF Subjects on Background Symdeko(TM) Therapy
Nov 01, 2017
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference
Oct 12, 2017
Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, & Geography) and Pipeline Analysis - Global Forecast to 2024
Oct 12, 2017
Global $41 Bn Respiratory Drugs Market to 2023 - Leading Players are GSK, AstraZeneca and Boehringer Ingelheim
Jul 24, 2017
Global Cystic Fibrosis Therapeutics Market 2016-2022: Profiles of Key players - Genentech, Novartis, Vertex, Abbott, Gilead Sciences & Allergan
Jun 27, 2017
Cystic Fibrosis Therapeutics Market Size Worth $13.9 Billion By 2025: Grand View Research, Inc.